BIIB
Biogen
$200.14
−$2.04 (−1.01%)Jul 27, 2026
Key metrics
The numbers that frame BIIB today
- Market cap
- $29.55B
- P/E (TTM)
- 21.5
- EV / FCF
- 13.6
- Gross margin
- 75.5%
- EV / Sales
- 3.3
- ROIC
- 12%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $124.56
- 52wk High
- $219.72
Growth
Revenue and earnings trend for BIIB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIIB
Is Biogen a good buy?
Yes. Biogen has excellent quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Biogen is selling at a low price.
What is the market capitalization of BIIB?
Biogen's market capitalization is $29.55B.
What is the P/E ratio for BIIB stock?
Biogen's current P/E ratio is 21.5.
What is the 52-week high for BIIB stock?
The 52-week high for Biogen is $219.72. The current close of $200.14 is 8.9% below that high.
What is the 52-week low for BIIB stock?
The 52-week low for Biogen is $124.56. The current close of $200.14 is 60.7% above that low.
Does BIIB stock pay dividends?
Biogen does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIIB?
Biogen's Debt / Equity ratio is 0.35.